Amneal Pharmaceuticals, Inc. (AMRX)
14.43
-0.07
(-0.48%)
USD |
NASDAQ |
Feb 23, 14:06
Amneal Pharmaceuticals Profit Margin (Quarterly) : 2.31% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 9.32% |
| Pfizer Inc. | -9.34% |
| Apellis Pharmaceuticals, Inc. | 47.04% |
| Nektar Therapeutics | -301.3% |
| Innoviva, Inc. | 80.81% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 1.66% |
| Return on Invested Capital | 2.24% |
| Gross Profit Margin (Quarterly) | 34.92% |
| Operating Margin (Quarterly) | 9.28% |
| Return on Net Operating Assets | 1.76% |